GlaxoSmithKline (GSK): Q4 core EPS of 32.6 pence beats by 1.3 pence; Revenues of £6.80B (-3%...

|About: GlaxoSmithKline (GSK)|By:, SA News Editor
GlaxoSmithKline (GSK): Q4 core EPS of 32.6 pence beats by 1.3 pence; Revenues of £6.80B (-3% Y/Y) misses by £80M. Net profit -35% to £839M. Shares +0.2%. (PR)